Vasconcellos, Erica de Camargo Ferreira E <br/><br/>
Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).  [electronic resource] 

 -  The American journal of tropical medicine and hygiene  Aug 2012 
 - 257-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-1645 
<br/><br/><label>Standard No.: </label>10.4269/ajtmh.2012.11-0612  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiprotozoal Agents--administration & dosage<br/>Brazil<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Injections, Intralesional<br/>Leishmania--growth & development<br/>Leishmaniasis, Cutaneous--drug therapy<br/>Male<br/>Meglumine--administration & dosage<br/>Meglumine Antimoniate<br/>Middle Aged<br/>Organometallic Compounds--administration & dosage<br/>Statistics, Nonparametric<br/>Urban Population<br/>Young Adult